Google
CODX — CO-DIAGNOSTICS, INC. COMMON STOCK (Healthcare >> Medical Devices)
CODX FAQ
What is CODX's ROE?
CO-DIAGNOSTICS, INC. COMMON STOCK reports a Return on Equity (ROE) of -302.34%.
What is CODX's dividend yield?
CO-DIAGNOSTICS, INC. COMMON STOCK offers a dividend yield of 0.00%.
What is CODX's Deepscope Quality Score?
Deepscope rates CODX's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CODX?
Deepscope's AI Timing Score for CODX is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CODX belong to?
CO-DIAGNOSTICS, INC. COMMON STOCK is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 5.76
Price
0.59
(11.41%)
Day Change
|
|
|---|
CODX, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 92 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 5.76 |
| PBV / Sector |
1.14 / 7.50
GREAT
|
| Earning Per Share | -15.32 |
| PE / Sector |
N/A / 28.68
|
| PEG or PE/Growth / Sector |
N/A / 0.39
|
| Average 1M Daily Value |
73.48 M
|
| Average 1W Daily Value |
18.25 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-05 09:11:34 |
| Symbol | CODX |
| Name | CO-DIAGNOSTICS, INC. COMMON STOCK |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 3.69 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 18.24 / 18,060.39 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2401 S. Foothill Drive, Salt Lake City, UT, United States, 84109
Phone: 801 438 1036
Website: https://co-dx.com
Employees: 115
Sector: Healthcare >> Medical Devices
Description: Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
